Clinical response to unintended infusion of doxorubicin and vincristine over one instead of four days

James Waddell, Teresa A. Coleman

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Straightforward reports of unusual drug experiences are included in this section. While selected references may be cited, the purpose of a Drug Experience report is not to present an extensive review of the literature. A related section, Grand Rounds, includes papers that are well-documented patient case reports with a thorough review of the important literature to help put the case in perspective. Authors should report serious adverse drug reactions to the FDA medical products reporting program (MedWatch). Such reporting will not jeopardize the chances that AJHP will publish manuscripts on the same drug reactions.

Original languageEnglish (US)
Pages (from-to)1242-1244
Number of pages3
JournalAmerican Journal of Health-System Pharmacy
Volume57
Issue number13
StatePublished - Jul 1 2000
Externally publishedYes

Fingerprint

Vincristine
Doxorubicin
Pharmaceutical Preparations
Teaching Rounds
Manuscripts
Drug-Related Side Effects and Adverse Reactions

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Health Policy

Cite this

Clinical response to unintended infusion of doxorubicin and vincristine over one instead of four days. / Waddell, James; Coleman, Teresa A.

In: American Journal of Health-System Pharmacy, Vol. 57, No. 13, 01.07.2000, p. 1242-1244.

Research output: Contribution to journalArticle

@article{53b1833e83fc47e894df5f8bb0317d34,
title = "Clinical response to unintended infusion of doxorubicin and vincristine over one instead of four days",
abstract = "Straightforward reports of unusual drug experiences are included in this section. While selected references may be cited, the purpose of a Drug Experience report is not to present an extensive review of the literature. A related section, Grand Rounds, includes papers that are well-documented patient case reports with a thorough review of the important literature to help put the case in perspective. Authors should report serious adverse drug reactions to the FDA medical products reporting program (MedWatch). Such reporting will not jeopardize the chances that AJHP will publish manuscripts on the same drug reactions.",
author = "James Waddell and Coleman, {Teresa A.}",
year = "2000",
month = "7",
day = "1",
language = "English (US)",
volume = "57",
pages = "1242--1244",
journal = "American Journal of Health-System Pharmacy",
issn = "1079-2082",
publisher = "American Society of Health-Systems Pharmacy",
number = "13",

}

TY - JOUR

T1 - Clinical response to unintended infusion of doxorubicin and vincristine over one instead of four days

AU - Waddell, James

AU - Coleman, Teresa A.

PY - 2000/7/1

Y1 - 2000/7/1

N2 - Straightforward reports of unusual drug experiences are included in this section. While selected references may be cited, the purpose of a Drug Experience report is not to present an extensive review of the literature. A related section, Grand Rounds, includes papers that are well-documented patient case reports with a thorough review of the important literature to help put the case in perspective. Authors should report serious adverse drug reactions to the FDA medical products reporting program (MedWatch). Such reporting will not jeopardize the chances that AJHP will publish manuscripts on the same drug reactions.

AB - Straightforward reports of unusual drug experiences are included in this section. While selected references may be cited, the purpose of a Drug Experience report is not to present an extensive review of the literature. A related section, Grand Rounds, includes papers that are well-documented patient case reports with a thorough review of the important literature to help put the case in perspective. Authors should report serious adverse drug reactions to the FDA medical products reporting program (MedWatch). Such reporting will not jeopardize the chances that AJHP will publish manuscripts on the same drug reactions.

UR - http://www.scopus.com/inward/record.url?scp=0034235870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034235870&partnerID=8YFLogxK

M3 - Article

VL - 57

SP - 1242

EP - 1244

JO - American Journal of Health-System Pharmacy

JF - American Journal of Health-System Pharmacy

SN - 1079-2082

IS - 13

ER -